BREAKING NEWS

AstraZeneca to acquire Alexion in $39 bln deal

Astrazeneca Plc will acquire US based Alexion Pharmaceuticals in a $39 billion deal, the company said in a statement on Saturday.
Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share, the company said.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use

Read all Tweets >